ANTI-ADALIMUMAB ANTIBODIES (ADL) - ANVISA Registration 10350840429
Access comprehensive regulatory information for ANTI-ADALIMUMAB ANTIBODIES (ADL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840429 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including IMMUNDIAGNOSTIK, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10350840429
25351420179202282
02220795000179
Company Information
Dates and Status
Nov 07, 2022
VIGENTE
09/18/2025 19:00:01
ADALIMUMAB (ADL)
FamÃlia AFIAS Adalimumab
BODITECH MED INC.
10350840428
Oct 27, 2022
ANTI-INFLIXIMAB (IFX) ANTIBODIES
FamÃlia AFIAS Free Anti-Infliximab
BODITECH MED INC.
10350840427
Oct 27, 2022
ANTI-INFLIXIMAB (IFX) ANTIBODIES
FamÃlia AFIAS Total Anti-Infliximab
BODITECH MED INC.
10350840430
Nov 07, 2022
INFLIXIMAB (IFX)
FamÃlia AFIAS Infliximab
BODITECH MED INC.
10350840426
Oct 20, 2022
ULTRASENSITIVE C-REACTIVE PROTEIN
FamÃlia AFIAS hsCRP
BODITECH MED INC.
10350840462
Nov 04, 2024
ANTICORPOS ANTI-ADALIMUMAB (ADL)
Quantum Blue® Anti-Adalimumab
BUHLMANN LABORATORIES AG
80102512669
Jun 10, 2021
ANTICORPOS ANTI-ADALIMUMAB (ADL)
IDKmonitor® Adalimumab free ADA ELISA
IMMUNDIAGNOSTIK
80464810759
Feb 11, 2021
ANTICORPOS ANTI-ADALIMUMAB (ADL)
IDKmonitor® Adalimumab total ADA ELISA
IMMUNDIAGNOSTIK
80464810760
Feb 11, 2021
ANTICORPOS ANTI-ADALIMUMAB (ADL)
PROMONITOR ANTI-ADL
PROGENIKA BIOPHARMA S.L.
80134860235
Jul 03, 2017